Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year
Authors
Keywords
-
Journal
Current Urology Reports
Volume 13, Issue 1, Pages 16-23
Publisher
Springer Nature
Online
2011-12-03
DOI
10.1007/s11934-011-0232-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Benefit of cytoreductive nephrectomy in metastatic RCC: do we learn from retrospective studies and small prospective studies?
- (2011) B. Escudier ANNALS OF ONCOLOGY
- The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
- (2011) T. Powles et al. ANNALS OF ONCOLOGY
- Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
- (2011) Judith Manola et al. CLINICAL CANCER RESEARCH
- Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma
- (2011) Brian F. Chapin et al. EUROPEAN UROLOGY
- ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic Disease
- (2011) Jean-Jacques Patard et al. EUROPEAN UROLOGY
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Clinical Evidence
- (2011) T. E. Hutson ONCOLOGIST
- New Perspectives on the Treatment of Metastatic Renal Cell Carcinoma: An Introduction and Historical Overview
- (2011) R. J. Motzer ONCOLOGIST
- Treatment-Associated Adverse Event Management in the Advanced Renal Cell Carcinoma Patient Treated with Targeted Therapies
- (2011) A. Ravaud ONCOLOGIST
- Clinical Practice Guidelines for the Treatment of Metastatic Renal Cell Carcinoma: Today and Tomorrow
- (2011) A. M. Molina et al. ONCOLOGIST
- A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
- (2011) N. Suwaki et al. Science Translational Medicine
- Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy
- (2010) S. L. Richey et al. ANNALS OF ONCOLOGY
- Hypothyroidism in patients with renal cell carcinoma
- (2010) Manuela Schmidinger et al. CANCER
- A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2
- (2010) J. P. Eder et al. CLINICAL CANCER RESEARCH
- Integrating Surgery with Targeted Therapies for Renal Cell Carcinoma: Current Evidence and Ongoing Trials
- (2010) Axel Bex et al. EUROPEAN UROLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Potent Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitors: Synthesis, Structure−Activity Relationships, and Antitumor Activities of 2-Indolinone Derivatives
- (2010) Peng Cho Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
- (2010) Michael L. Maitland et al. JNCI-Journal of the National Cancer Institute
- Metastasectomy After Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
- (2010) Jose A. Karam et al. JOURNAL OF UROLOGY
- The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy
- (2010) Toni K. Choueiri et al. JOURNAL OF UROLOGY
- Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new
- (2010) Kyle A Furge et al. LANCET ONCOLOGY
- Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study
- (2010) H. J. Hammers et al. MOLECULAR CANCER THERAPEUTICS
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- Multi-modal treatment for metastatic renal cancer: the role of surgery
- (2010) Paul Russo WORLD JOURNAL OF UROLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started